India Vaccine Tycoon Calls Covid Booster Shots 'unethical'
Mohammad Ali (@ChaudhryMAli88) Published September 17, 2021 | 07:20 PM
Mumbai, Sept 17 (UrduPoint / Pakistan Point News - 17th Sep, 2021 ) :The head of the world's largest vaccine maker said Friday it was "unethical" to give third doses of the Covid-19 vaccine while developing nations are struggling to access first and second jabs.
Adar Poonawalla, billionaire chief executive of Serum Institute of India, spoke out as he announced a $4.9 billion deal to take a 15 percent stake in a rival pharma firm, allowing vaccine production to be ramped up.
Israel was the first country to recommend Covid-19 booster doses in July and several European nations have since followed, targeting high-risk groups.
The United States, which is suffering rising coronavirus cases, is expected to roll out booster doses from next week.
"It's unethical to start giving three doses to somebody when others in certain countries and populations have not even got two doses," Poonawalla told reporters.
He added it was "not right" to roll out booster shots when poorer countries have "not been able to get the vaccines purely because the rich nations have taken away most of the vaccines.
" Serum Institute is currently producing 160 million doses of Astra-Zeneca's Covishield each month, but Poonawalla said this would go up to 200 million from October.
Despite India's export ban because of shortages that have hit the domestic vaccination drive, he said he expects restrictions will "slowly ease in the next month or two".
He acknowledged that "some very vulnerable sections" could benefit from booster shots, but added: "There is no evidence to say so far that Covishield requires a third dose." Serum Institute is taking a stake in fellow pharma billionaire Kiran Mazumdar Shaw's Biocon Biologics.
Under the deal, Biocon will be able to manufacture and sell 100 million vaccine doses annually -- including Covishield and Covavax, Serum's Novavax vaccine for children, currently undergoing trials.
Poonawalla said both companies were ramping up research for a potential new-style messenger RNA vaccine, similar to Pfizer and Moderna's Covid-19 products.
Related Topics
Recent Stories
Robinson, bowlers help New Zealand go 2-1 up against Pakistan
Shahzeb Chachar to hold khuli kachehri on April 26
Heatwave amid Israel's aggression in Gaza brings new misery, disease risk
Tourism must change, mayor says as Venice launches entry fee
Court adjourns Judicial Complex attack case till May 17
Nasreen Noori’s book ‘Popatan Jahra Khwab’ launched
Wafaqi Mohtasib inspection team visits Excise and taxation office
AJLAC announces 5th Conference titled ‘People’s Mandate: Safeguarding Civil ..
Pak-US officials engage to enhance trade, investment ties
IBCC to promote educational excellence, expand regional presence
Pakistani 'Blue Helmets' serving UN Peacekeeping Mission in DR Congo set to leav ..
Putin says plans to visit China in May
More Stories From Miscellaneous
-
PDMA predicts gusty wind, rain with thunder, hails
2 days ago -
Iranian president Raisi given guard of honour at PM House
4 days ago -
Intellectuals, writers accolades Naseer Mirza on his literary contribution
4 days ago -
Bahawalpur Adabi Sangat hosts memorable mushaira
4 days ago -
Cattle farming vital to alleviate poverty in rural areas
5 days ago -
Pakistan: A land of tourism, archeological wonders
5 days ago
-
Transforming education sector: from job hunters to job creators
7 days ago -
Amjad Bobby remembered on 19th death anniversary for timeless contributions to music
11 days ago -
Legendary actor Nadeem’s 26 films released on Eid-ul-Fitr days in 50 years
11 days ago -
Besant Hall Cultural Centre to celebrate evening with Sanam Marvi on 26 April
12 days ago -
Radio Bahawalpur presents program “Eidi Shidi”
15 days ago -
Radio Bahawalpur to broadcast Eid programs
17 days ago